| Spirig HealthCare AG - Sitagliptin Metformin XR Spirig HC 50/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung | | 69160 | | 02 | | Sitagliptin Metformin XR Spirig HC 50/1000 mg | | Tabletten mit veränderter Wirkstofffreisetzung | | A10BD07 | | Metformine et Sitagliptine | | 03.08.2023 | | |
| | Composition | | metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, pro compresso, natrium 2.1 mg. | | Packungsbestandteile | | Comprimés | | | | | Principe actif | Concentr. |
|---|
| Metformine Hydrochloride | 1000 mg | | Sitagliptine | 50 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Metformine Hydrochloride | 1000 mg | | Sitagliptine | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Calcium Hydrogenophosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Natrii Stearylis Fumaras | | | | Sodium | 2.1 mg | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso | | | | Talcum | | |
| |
| |
|
